AI-generated from publicly available materials.The Technology Development Board (TDB) has partnered with Griva Healthcare to enhance early cancer screening through the introduction of the AI-powered portable digital colposcope, GrivaVision.
This collaboration aims to facilitate the manufacturing and commercialization of GrivaVision, a device designed to assist gynecologists in visualizing the vaginal canal and examining cervical lesions effectively. With features like a high-definition camera and advanced optics, GrivaVision integrates indigenous AI software to support routine clinical examinations.
The TDB will help establish manufacturing capabilities in Kollam, Kerala, which is expected to make cervical cancer screening more accessible, especially in primary healthcare settings. This initiative not only aims to reduce reliance on imported diagnostic tools but also enhances domestic production capabilities in advanced medical devices. GrivaVision complies with WHO standards for Automated Visual Assessment and is designed to integrate seamlessly into India's digital health ecosystem.
Rajesh Kumar Pathak, Secretary of TDB, emphasized the importance of early detection in combating cervical cancer. He noted that innovations like GrivaVision exemplify the potential of combining medical technology, digital health, and AI to meet critical healthcare needs effectively. This partnership is poised to shift the focus from research and development to commercial manufacturing, ultimately strengthening India's self-reliance in medical technology.